Chemtours Company Reports $530,000 in Q1 2025 Lobbying Expenses

The Chemours Company disclosed $530,000 in lobbying expenditures for Q1 2025, as outlined in a recent Lobbying Disclosure Act filing.

Lobbying Focus Areas

The company’s lobbying covered several key issues, including:

• Rail regulatory reform and general transportation issues concerning rail and water infrastructure.
• Water resources development and the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58).
• Concerns regarding PFAS and hydrofluorocarbon phasedown.
• Semiconductor supply chain and specific legislation such as the PFAS Action Act of 2023 (H.R. 6805).
• Draft legislation from the Senate Committee on Environment and Public Works addressing PFAS.
• Implementation aspects of the Frank R. Lautenberg Chemical Safety for the 21st Century Act (P.L. 114-182), particularly Sections 5 and 6.
• Trade challenges relating to fluorochemicals, focusing on trade barriers and antidumping issues.
• General discussions around tariff implementation in regard to several executive orders.
• Tax implications under the Tax Cuts and Jobs Act (P.L. 115-97) and the Inflation Reduction Act of 2022 (P.L. 117-169).
• Defense-related issues, particularly concerning critical minerals and renewable energy generation.
• Proposed implementation of the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-31).
• Emerging topics in technology, such as data centers and cooling technologies.

You can find more data on corporate lobbying at Quiver Quantitative.

Insider Trading Activity

In the past six months, insiders at Chemours have executed only one trade involving $CC stock. All transactions comprised one sale, with no purchases made.

Here is a breakdown of the most recent insider trading activities:

• ALVENIA SCARBOROUGH (SVP Corp Communications & CBO) sold 7,500 shares for an estimated $154,770.

For further tracking of insider transactions, visit Quiver Quantitative’s insider trading dashboard.

Hedge Fund Movements

Recently, 195 institutional investors increased their positions in CC stock, while 163 decreased their holdings in the last quarter.

Here are some significant changes:

• FMR LLC decreased their portfolio by 3,339,468 shares (-18.4%), estimated at $56,437,009, in Q4 2024.
• VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. exited with a complete removal of 2,166,741 shares (-100.0%), valued at $36,617,922.
• UBS GROUP AG considerably increased their position, adding 1,863,861 shares (+867.9%), worth approximately $31,499,250.
• KHROM CAPITAL MANAGEMENT LLC reduced holdings by 1,159,331 shares (-34.7%), estimated at $19,592,693.
• LUMINUS MANAGEMENT LLC cut holdings by 1,014,661 shares (-62.8%), valued at $17,147,770.
• BANK OF MONTREAL significantly increased their holdings by 893,530 shares (+1496.4%), worth $15,100,656.
• APPIAN WAY ASSET MANAGEMENT LP added 851,603 shares (+50.7%), for an estimated value of $14,392,090.

For an overview of hedge funds’ stock portfolios, view Quiver Quantitative’s institutional holdings dashboard.

This article is for informational purposes only and is not financial advice. For more details, refer to Quiver Quantitative’s disclaimers.

This article was originally published on Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.